Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
DarioHealth ( (DRIO) ) has issued an announcement.
On March 12, 2025, DarioHealth Corp. made a significant change in its auditing firm by appointing Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as its new independent registered public accounting firm, replacing Kost, Forer, Gabbay & Kasierer, a member of Ernst & Young Global. The transition comes after EY’s audit reports for the fiscal years 2023 and 2024, which were unqualified and without disagreements or reportable events, indicating a smooth handover. This strategic move might influence DarioHealth’s financial reporting and auditing processes, potentially impacting its stakeholders and market perception.
More about DarioHealth
YTD Price Performance: -20.98%
Average Trading Volume: 740,680
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $26.19M
For detailed information about DRIO stock, go to TipRanks’ Stock Analysis page.